[go: up one dir, main page]

MX2019008320A - Metodo para la deteccion prenatal no invasiva de aneuploidia. - Google Patents

Metodo para la deteccion prenatal no invasiva de aneuploidia.

Info

Publication number
MX2019008320A
MX2019008320A MX2019008320A MX2019008320A MX2019008320A MX 2019008320 A MX2019008320 A MX 2019008320A MX 2019008320 A MX2019008320 A MX 2019008320A MX 2019008320 A MX2019008320 A MX 2019008320A MX 2019008320 A MX2019008320 A MX 2019008320A
Authority
MX
Mexico
Prior art keywords
fetal
present
methods
aneuploidy
relative abundance
Prior art date
Application number
MX2019008320A
Other languages
English (en)
Inventor
Zhang Ke
Strom Charles
Rowland Charles
OWEN Renius
Original Assignee
Quest Diagnostics Invest Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Diagnostics Invest Llc filed Critical Quest Diagnostics Invest Llc
Publication of MX2019008320A publication Critical patent/MX2019008320A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/20—Sequence assembly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B20/00—Methods specially adapted for identifying library members
    • C40B20/04—Identifying library members by means of a tag, label, or other readable or detectable entity associated with the library members, e.g. decoding processes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención proporciona métodos para la detección prenatal no invasiva (DPNI) de aneuploidías fetales. Los métodos de la presente invención se fundamentan en el análisis de ADN fetal libre de células (ADNfIc) encontrado en la circulación de una mujer embarazada, mediante tecnología de secuenciación de última generación (SUG). Particularmente, los métodos de la presente invención analizan la abundancia relativa de diferentes fragmentos genómicos fetales presentes en la muestra materna, en donde los fragmentos pueden ser alineados a localizaciones cromosómicas particulares del genoma fetal. La información sobre la abundancia relativa es indicativa de si un cromosoma particular está sobrerrepresentado o subrepresentado en el genoma fetal, en comparación con individuos normales, y por lo tanto, se puede usar para detectar aneuploidía fetal. Además, también se proporcionan métodos para incrementar los valores predictivos positivos (VPP) de DPNIs mediante la exclusión de los falsos positivos detectados.
MX2019008320A 2017-01-11 2018-01-10 Metodo para la deteccion prenatal no invasiva de aneuploidia. MX2019008320A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762445196P 2017-01-11 2017-01-11
PCT/US2018/013055 WO2018132400A1 (en) 2017-01-11 2018-01-10 Method for non-invasive prenatal screening for aneuploidy

Publications (1)

Publication Number Publication Date
MX2019008320A true MX2019008320A (es) 2019-09-09

Family

ID=62840332

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019008320A MX2019008320A (es) 2017-01-11 2018-01-10 Metodo para la deteccion prenatal no invasiva de aneuploidia.
MX2025008751A MX2025008751A (es) 2017-01-11 2019-07-10 Metodo para la deteccion prenatal no invasiva de aneuploidia

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2025008751A MX2025008751A (es) 2017-01-11 2019-07-10 Metodo para la deteccion prenatal no invasiva de aneuploidia

Country Status (7)

Country Link
US (2) US20200255896A1 (es)
EP (2) EP3568472B1 (es)
CN (1) CN110770341A (es)
BR (1) BR112019014208A2 (es)
CA (1) CA3049442A1 (es)
MX (2) MX2019008320A (es)
WO (1) WO2018132400A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3827094A1 (en) * 2018-07-24 2021-06-02 Affymetrix, Inc. Array based method and kit for determining copy number and genotype in pseudogenes
RU2712175C1 (ru) * 2019-11-14 2020-01-24 Общество с ограниченной ответственностью "НИПТ" (ООО "НИПТ") Способ неинвазивного пренатального скрининга анеуплоидий плода
CA3141362A1 (en) * 2019-12-31 2021-07-08 Bgi Clinical Laboratories (Shenzhen) Co., Ltd. Method and device for determining chromosomal aneuploidy and constructing classification model
CN112037846A (zh) * 2020-07-14 2020-12-04 广州市达瑞生物技术股份有限公司 一种cffDNA非整倍体检测方法、系统、储存介质以及检测设备
CN111951890B (zh) * 2020-08-13 2022-03-22 北京博昊云天科技有限公司 染色体和单基因病同步产前筛查的设备、试剂盒和分析系统
CN113046430B (zh) * 2021-03-15 2022-02-01 北京阅微基因技术股份有限公司 一种染色体非整倍体数目异常的扩增组合物及其应用
CN113643755B (zh) * 2021-08-11 2023-10-13 上海小海龟科技有限公司 一种nipt试剂盒阳性率校正方法、装置、计算机设备和介质
CN113744892A (zh) * 2021-09-02 2021-12-03 上海宝藤生物医药科技股份有限公司 胚胎整倍性预测方法、装置、电子设备及存储介质
CN118969092A (zh) * 2022-12-30 2024-11-15 深圳市真迈生物科技有限公司 胎儿浓度的确定方法及装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2183693B2 (en) * 2007-07-23 2018-11-14 The Chinese University of Hong Kong Diagnosing fetal chromosomal aneuploidy using genomic sequencing
BR122021021825B1 (pt) * 2012-09-20 2022-05-24 The Chinese University Of Hong Kong Método para estimar um nível de metilação de dna em uma amostra biológica de um organismo, e, meio de armazenamento de memória
US10643738B2 (en) * 2013-01-10 2020-05-05 The Chinese University Of Hong Kong Noninvasive prenatal molecular karyotyping from maternal plasma
US10319463B2 (en) 2015-01-23 2019-06-11 The Chinese University Of Hong Kong Combined size- and count-based analysis of maternal plasma for detection of fetal subchromosomal aberrations

Also Published As

Publication number Publication date
BR112019014208A2 (pt) 2020-03-17
EP3568472A1 (en) 2019-11-20
US20200255896A1 (en) 2020-08-13
MX2025008751A (es) 2025-09-02
EP4667587A2 (en) 2025-12-24
CA3049442A1 (en) 2018-07-19
WO2018132400A1 (en) 2018-07-19
EP3568472A4 (en) 2020-08-12
US20250257404A1 (en) 2025-08-14
EP3568472B1 (en) 2025-09-03
CN110770341A (zh) 2020-02-07

Similar Documents

Publication Publication Date Title
MX2019008320A (es) Metodo para la deteccion prenatal no invasiva de aneuploidia.
BR112018008532A2 (pt) detecção de aneuploidias cromossômicas do feto usando regiões de dna que são metiladas de forma diferenciada entre o feto e a mulher grávida
Papageorgiou et al. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21
CL2021003030A1 (es) Detección rápida de aneuploidía
ES3047391T3 (en) Methods and processes for non-invasive assessment of genetic variations
GB2484764B (en) Normalizing chromosomes for the determination and verification of common and rare chromosomal aneuploidies
AU2014205038A8 (en) Noninvasive prenatal molecular karyotyping from maternal plasma
IL317916A (en) Methods and processes for assessing genetic mosaicism
EA201891580A1 (ru) Применение размера фрагмента бесклеточной днк для определения вариаций числа копий
RU2012158107A (ru) Неинвазивное обнаружение генетической аномалии плода
EP3271481B1 (en) Methods of quality control using single-nucleotide polymorphisms in pre-implantation genetic screening
MX2021012988A (es) Metodos y sistemas de analisis de microsatelite.
WO2021079158A8 (en) Prostate cancer detection methods
Hatt et al. Microarray-based analysis of methylation of 1st trimester trisomic placentas from down syndrome, edwards syndrome and patau syndrome
CY1121234T1 (el) Μεθοδος για μη-επεμβατικη προγεννητικη ανιχνευση του ευπλοιδικου εμβυικου χρωμοσωματος απο το μητρικο αιμα
Greene et al. Screening for trisomies in circulating DNA
Nathalang et al. Risk estimation of HNA-3 incompatibility and alloimmunization in Thai populations
US20250092446A1 (en) Methods of methylation analysis for disease detection
BR112018011141A2 (pt) método para detectar o gênero fetal e as anormalidades no número de cópias, aparelho e meio legível por computador para realizar o mesmo
PH12021550429A1 (en) Non-invasive prenatal testing method using maternal cell-free dna fragment
Thomas Junior et al. The development and applications of circulating tumour cells, circulating tumour DNA and other emerging biomarkers for early cancer detection.
WO2020123880A3 (en) Genomic rearrangements associated with prostate cancer and methods of using the same
DK1766088T3 (da) Identificering af kromosomabnormaliteter i celler, der opnået fra follikelvæske
Thien Nguyen et al. Evaluation of a multimodal ctDNA-based assay for detection of aggressive cancers lacking standard screening tests
Wilson et al. Statistical framework for studying the spatial architecture of the tumor immune microenvironment